You have 2 free searches left this month | for more free features.

cord blood stem cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Cerebral Palsy Trial in Augusta (Cord Blood Infusion, Intravenous Sham)

Withdrawn
  • Cerebral Palsy
  • Cord Blood Infusion
  • Intravenous Sham
  • Augusta, Georgia
    Augusta University
Oct 6, 2022

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Neonatal Hypoxic-ischaemic Encephalopathy Trial in Marseille (autologous cord blood stem cell)

Recruiting
  • Neonatal Hypoxic-ischaemic Encephalopathy
  • autologous cord blood stem cell
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Aug 12, 2022

Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)

Not yet recruiting
  • Bone Marrow Transplant
  • Stem Cell Transplant
  • Zoster Vaccine Recombinant
  • Aurora, Colorado
    University of Colorado Hospital
Mar 17, 2023

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
  • Myeloid Hematological Malignancies
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

Hypoplastic Left Heart Syndrome, Heart Defects, Congenital, Pediatric Disorder Trial in Melbourne (Autologous Human Placental

Completed
  • Hypoplastic Left Heart Syndrome
  • +2 more
  • Autologous Human Placental Cord Blood Mononuclear Cells
  • Melbourne, Victoria, Australia
    Royal Children's Hospital
Jul 19, 2022

Congenital Pediatric Disorders Trial in Houston (Busulfan, Cytoxan, Fludarabine)

Active, not recruiting
  • Congenital Pediatric Disorders
  • Houston, Texas
    Texas Children's Hospital
Feb 4, 2022

Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,

Recruiting
  • Acute Leukemia
  • Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
  • haploidentical hematopoietic stem cell transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Aug 9, 2022

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Cerebral Palsy Trial in Houston (Umbilical Cord Blood Stem Cells, Saline Infusion (Placebo), Bone Marrow Stem Cells)

Completed
  • Cerebral Palsy
  • umbilical cord blood (hUCB) cells
  • +2 more
  • Houston, Texas
    UTHealth, Medical School, Dept. of Pediatric Surgery
Oct 27, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023

Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB

Withdrawn
  • Sickle Cell Disease
  • +2 more
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • Palo Alto, California
  • +1 more
Jun 29, 2022

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

Completed
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • +5 more
  • Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
  • GVHD prophylaxis
  • Duarte, California
  • +15 more
Nov 2, 2021

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human

Completed
  • Mucopolysaccharidosis I
  • +15 more
  • Human Placental Derived Stem Cell
  • Denver, Colorado
  • +2 more
Oct 24, 2022

Stem Cell Transplantation Trial in Durham (Thymic Transplantation for Recipients of UCB transplant)

Terminated
  • Stem Cell Transplantation
  • Thymic Transplantation for Recipients of UCB transplant
  • Durham, North Carolina
    Duke University Health System
Mar 21, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Ischemic Stroke Trial in Hanoi (UC-MSC infusion via intravenous route, UC-MSC infusion via intrathecal route, standard stroke

Recruiting
  • Ischemic Stroke
  • UC-MSC infusion via intravenous route
  • +2 more
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Mar 22, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord

Completed
  • Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
  • Severe Aplastic Anemia (SAA)
  • Umbilical Cord Blood
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 16, 2021